| CD56brightCD16− killer Ig-like receptor− NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation C Romagnani, K Juelke, M Falco, B Morandi, A D’Agostino, R Costa, ... The Journal of Immunology 178 (8), 4947-4955, 2007 | 608 | 2007 |
| CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells S Sivori, M Falco, MD Chiesa, S Carlomagno, M Vitale, L Moretta, ... Proceedings of the National Academy of Sciences 101 (27), 10116-10121, 2004 | 584 | 2004 |
| X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill … S Parolini, C Bottino, M Falco, R Augugliaro, S Giliani, R Franceschini, ... The Journal of experimental medicine 192 (3), 337-346, 2000 | 546 | 2000 |
| HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells. M Colonna, G Borsellino, M Falco, GB Ferrara, JL Strominger Proceedings of the National Academy of Sciences 90 (24), 12000-12004, 1993 | 527 | 1993 |
| HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders A Bertaina, P Merli, S Rutella, D Pagliara, ME Bernardo, R Masetti, ... Blood, The Journal of the American Society of Hematology 124 (5), 822-826, 2014 | 484 | 2014 |
| Valsartan for prevention of recurrent atrial fibrillation P Delise, F Bertocchi, G Maiocchi, E Geraci, E Correale, F Lombardi, ... New England Journal of Medicine 360 (16), 1606-1617, 2009 | 473 | 2009 |
| Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the … D Pende, GM Spaggiari, S Marcenaro, S Martini, P Rivera, A Capobianco, ... Blood 105 (5), 2066-2073, 2005 | 463 | 2005 |
| Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and … D Pende, S Marcenaro, M Falco, S Martini, ME Bernardo, D Montagna, ... Blood, The Journal of the American Society of Hematology 113 (13), 3119-3129, 2009 | 444 | 2009 |
| The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like … D Pende, R Biassoni, C Cantoni, S Verdiani, M Falco, C Di Donato, ... The Journal of experimental medicine 184 (2), 505-518, 1996 | 413 | 1996 |
| Mitochondria as playmakers of apoptosis, autophagy and senescence M Abate, A Festa, M Falco, A Lombardi, A Luce, A Grimaldi, S Zappavigna, ... Seminars in cell & developmental biology 98, 139-153, 2020 | 405 | 2020 |
| Gntb-A, a Novel Sh2d1a-Associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected B Cells in X-Linked … C Bottino, M Falco, S Parolini, E Marcenaro, R Augugliaro, S Sivori, ... The Journal of experimental medicine 194 (3), 235-246, 2001 | 376 | 2001 |
| The human leukocyte antigen (HLA)-C-specific" activatory" or" inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their … R Biassoni, C Cantoni, M Falco, S Verdiani, C Bottino, M Vitale, R Conte, ... The Journal of experimental medicine 183 (2), 645-650, 1996 | 366 | 1996 |
| Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation D Pende, M Falco, M Vitale, C Cantoni, C Vitale, E Munari, A Bertaina, ... Frontiers in immunology 10, 461739, 2019 | 334 | 2019 |
| Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion F Locatelli, P Merli, D Pagliara, G Li Pira, M Falco, D Pende, R Rondelli, ... Blood, The Journal of the American Society of Hematology 130 (5), 677-685, 2017 | 319 | 2017 |
| Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C M Colonna, EG Brooks, M Falco, GB Ferrara, JL Strominger Science 260 (5111), 1121-1124, 1993 | 302 | 1993 |
| Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? M Della Chiesa, M Falco, M Podestà, F Locatelli, L Moretta, F Frassoni, ... Blood, The Journal of the American Society of Hematology 119 (2), 399-410, 2012 | 288 | 2012 |
| 2B4 functions as a co‐receptor in human NK cell activation S Sivori, S Parolini, M Falco, E Marcenaro, R Biassoni, C Bottino, ... European journal of immunology 30 (3), 787-793, 2000 | 274 | 2000 |
| Identification of NKp80, a novel triggering molecule expressed by human NK cells M Vitale, M Falco, R Castriconi, S Parolini, R Zambello, G Semenzato, ... European journal of immunology 31 (1), 233-242, 2001 | 271 | 2001 |
| Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis … R Biassoni, M Falco, A Cambiaggi, P Costa, S Verdiani, D Pende, ... The Journal of experimental medicine 182 (2), 605-609, 1995 | 267 | 1995 |
| Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells M Falco, R Biassoni, C Bottino, M Vitale, S Sivori, R Augugliaro, L Moretta, ... The Journal of experimental medicine 190 (6), 793-802, 1999 | 258 | 1999 |
